Literature DB >> 8746876

Perimenopausal changes in serum lipids and lipoproteins: a 7-year longitudinal study.

K Fukami1, K Koike, K Hirota, H Yoshikawa, A Miyake.   

Abstract

Although cross-sectional studies suggest considerable influence of menopause on serum lipids and lipoproteins in women, it is not exactly clear. During our 7-year longitudinal study, serum concentrations of total cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides and low-density lipoprotein (LDL) cholesterol were measured in 16 healthy perimenopausal women (aged 47-56 years at menopause) who had undergone annual examinations 4 years before and 3 years after menopause under a health examinations system in Osaka. Longitudinal design enabled us to study the natural course of serum lipids and lipoproteins. The results show that from 4 years before to 1 year after menopause, the serum concentration of total cholesterol and LDL cholesterol increased on average by 25 mg/dl (14%) and 20 mg/dl (19%), respectively. Serum concentrations of triglycerides and of HDL cholesterol remained virtually unchanged during the perimenopausal and postmenopausal periods. It was concluded that serum lipids and lipoproteins are thus significantly altered as a consequence of menopause, resulting in a more atherogenic profile in the postmenopausal period.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8746876     DOI: 10.1016/0378-5122(95)00927-d

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  12 in total

1.  Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause.

Authors:  Samar R El Khoudary; Patrick M Hutchins; Karen A Matthews; Maria M Brooks; Trevor J Orchard; Graziella E Ronsein; Jay W Heinecke
Journal:  J Clin Endocrinol Metab       Date:  2016-07-11       Impact factor: 5.958

Review 2.  Effect of menopausal hormone therapy on components of the metabolic syndrome.

Authors:  Dragana Lovre; Sarah H Lindsey; Franck Mauvais-Jarvis
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-05-27

Review 3.  Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones.

Authors:  Xuewen Wang; Faidon Magkos; Bettina Mittendorfer
Journal:  J Clin Endocrinol Metab       Date:  2011-04       Impact factor: 5.958

4.  Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation.

Authors:  Imke Janssen; Lynda H Powell; Sybil Crawford; Bill Lasley; Kim Sutton-Tyrrell
Journal:  Arch Intern Med       Date:  2008-07-28

5.  Meta-analysis of the effects of flaxseed interventions on blood lipids.

Authors:  An Pan; Danxia Yu; Wendy Demark-Wahnefried; Oscar H Franco; Xu Lin
Journal:  Am J Clin Nutr       Date:  2009-06-10       Impact factor: 7.045

6.  Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation.

Authors:  Carol A Derby; Sybil L Crawford; Richard C Pasternak; Maryfran Sowers; Barbara Sternfeld; Karen A Matthews
Journal:  Am J Epidemiol       Date:  2009-04-08       Impact factor: 4.897

7.  HDL (High-Density Lipoprotein) Subclasses, Lipid Content, and Function Trajectories Across the Menopause Transition: SWAN-HDL Study.

Authors:  Samar R El Khoudary ( سمر رياض الخضري ); Xirun Chen (陈曦润); Alexis Nasr ( ألكسس نصر ); Jeff Billheimer; Maria Mori Brooks; Dan McConnell; Trevor J Orchard; Sybil L Crawford; Karen A Matthews; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-03       Impact factor: 8.311

8.  Effects of the transition from premenopause to postmenopause on lipids and lipoproteins: quantification and related parameters.

Authors:  Eun Jeung Cho; Yun Joo Min; Min Seok Oh; Jee Eun Kwon; Jeung Eun Kim; Wang-Soo Lee; Kwang Je Lee; Sang-Wook Kim; Tae Ho Kim; Myung-A Kim; Chee Jeong Kim; Wang Seong Ryu
Journal:  Korean J Intern Med       Date:  2011-03-02       Impact factor: 2.884

9.  Effects of long-term moderate exercise and increase in number of daily steps on serum lipids in women: randomised controlled trial [ISRCTN21921919].

Authors:  Hiroko Sugiura; Haruo Sugiura; Kazue Kajima; Seyed Mohammad Mirbod; Hirotoshi Iwata; Toshio Matsuoka
Journal:  BMC Womens Health       Date:  2002       Impact factor: 2.809

10.  Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids.

Authors:  L Vehmanen; T Saarto; C Blomqvist; M-R Taskinen; I Elomaa
Journal:  Br J Cancer       Date:  2004-08-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.